专题：Renal Diseases and Glomerulopathies

This cluster of papers focuses on the pathophysiology, genetics, and clinical aspects of glomerular diseases, including nephrotic syndromes such as membranous nephropathy, focal segmental glomerulosclerosis, and IgA nephropathy. It covers topics such as podocyte biology, renal thrombotic microangiopathy, genetic kidney diseases, and the role of the kidney barrier function in disease development.
最新文献
Oleuropein attenuates the nephrotoxic effect of sunitinib in rats: Unraveling the potential role of SIRT6/Notch-1/NLRP-3/IL-1β axis

article Full Text OpenAlex

Complements and Their Role in Systemic Disorders

article Full Text OpenAlex

Long-term Outcomes of Lupus Nephritis in Comparison to Other CKD Etiologies

article Full Text OpenAlex

APRIL — Springtime for New IgA Nephropathy Therapy?

editorial Full Text OpenAlex

Role of Estimated Glomerular Filtration Rate in Clinical Research: The Never-Ending Matter

review Full Text OpenAlex

Clinical algorithm model based on cfDNA to predict SLE disease activity

article Full Text OpenAlex

Rational use of eculizumab in secondary atypical hemolytic uremic syndrome

article Full Text OpenAlex

Dapagliflozin attenuates renal fibrosis by suppressing angiotensin II/TGFβ signaling in diabetic mice

article Full Text OpenAlex

Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systematic review and meta-analysis

review Full Text OpenAlex

Metformin inhibits high glucose‐induced apoptosis of renal podocyte through regulating miR‐34a/SIRT1 axis

article Full Text OpenAlex

近5年高被引文献
Epidemiology of chronic kidney disease: an update 2022

review Full Text OpenAlex 2371 FWCI495.90949244

KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

article Full Text OpenAlex 2093 FWCI287.93313044

Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment

review Full Text OpenAlex 821 FWCI111.13539569

A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease

review Full Text OpenAlex 696 FWCI103.39931552

Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases

article Full Text OpenAlex 687 FWCI96.98402952

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

article Full Text OpenAlex 508 FWCI88.40113129

Kidney fibrosis: from mechanisms to therapeutic medicines

review Full Text OpenAlex 480 FWCI160.44551784

Membranous nephropathy

review Full Text OpenAlex 383 FWCI49.81280894

A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease

article Full Text OpenAlex 382 FWCI56.22809494

A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy

article Full Text OpenAlex 350 FWCI51.87605946